StockClub
RAPPRapport Therapeutics, Inc. Common Stock$ --
Rapport Therapeutics, Inc. Common Stock

Rapport Therapeutics, Inc. Common Stock

RAPP

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -
Operating Income
-39M USD
YoY -63.7%
Net Income
-34M USD
YoY -69.0%
EPS
-0.72$
YoY -620.0%

Revenue

$0
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
Actual
$0 (-)

Net Income

$-111.5M
FY2024 Q1$-22.7M
$-22.7M
Q1
FY2024 Q2$-40.8M
$-40.8M
Q2
FY2024 Q3$-58.3M
$-58.3M
Q3
FY2024 Q4$-78.3M
$-78.3M
Q4
FY2025 Q1$-24.1M
$-24.1M
Q1
FY2025 Q2$-50.8M
$-50.8M
Q2
FY2025 Q3$-77.7M
$-77.7M
Q3
FY2025 Q4$-111.5M
$-111.5M
Q4
Actual
$-33.2M (-42.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025IN-LINE
Actual:$0
Est:$0
FY2025IN-LINE
$0

Analyst Estimates